Replimune Group (REPL) earnings history
Most recent quarter
- Fiscal period
- Q1 2026
- Period end
- Jun 30, 2025
- EPS actual
- −$0.95
- EPS estimate
- −$0.79
- EPS surprise
- −19.57%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 7, 2025
Replimune reported fiscal Q1 2026 results on August 7, 2025, with a loss of $0.95 per share against an expected loss of $0.79, a 19.57% miss. The table shows no revenue and no revenue estimate for this quarter or any earlier one. Compared with fiscal Q1 2025, the loss widened from $0.78 per share.
Replimune reported a loss in all 20 quarters in the table. Its fiscal year ends in March. Full-year losses grew from $2.27 per share in fiscal 2022 to $2.99 in fiscal 2023 and $3.24 in fiscal 2024, before easing to $3.07 in fiscal 2025. The smallest quarterly loss in the table was $0.41, in Q4 2021, and the largest was the latest, $0.95 in Q1 2026. The company missed EPS estimates in 15 of 20 quarters, including the last three.
No report after August 2025 appears in the table. In past years, fiscal Q2 results came out between November 3 and November 12, and fiscal Q3 results in early to mid February. Newer figures will show whether the loss per share moves back from the $0.95 of fiscal Q1 2026.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q1 2026 | Aug 7, 2025 | −$0.79 | −$0.95 | −19.57% | $0.00 | SEC |
| Q4 2025 | May 22, 2025 | −$0.71 | −$0.82 | −15.82% | $0.00 | SEC |
| Q3 2025 | Feb 12, 2025 | −$0.72 | −$0.79 | −9.43% | $0.00 | SEC |
| Q2 2025 | Nov 12, 2024 | −$0.82 | −$0.68 | +17.41% | $0.00 | SEC |
| Q1 2025 | Aug 8, 2024 | −$0.86 | −$0.78 | +8.98% | $0.00 | SEC |
| Q4 2024 | May 16, 2024 | −$0.77 | −$0.82 | −6.76% | $0.00 | SEC |
| Q3 2024 | Feb 8, 2024 | −$0.89 | −$0.77 | +13.72% | $0.00 | SEC |
| Q2 2024 | Nov 7, 2023 | −$0.81 | −$0.90 | −10.65% | $0.00 | SEC |
| Q1 2024 | Aug 3, 2023 | −$0.80 | −$0.75 | +6.11% | $0.00 | SEC |
| Q4 2023 | May 18, 2023 | −$0.65 | −$0.73 | −11.55% | $0.00 | SEC |
| Q3 2023 | Feb 9, 2023 | −$0.75 | −$0.69 | +7.46% | $0.00 | SEC |
| Q2 2023 | Nov 3, 2022 | −$0.75 | −$0.79 | −5.03% | $0.00 | — |
| Q1 2023 | Aug 4, 2022 | −$0.60 | −$0.78 | −29.07% | $0.00 | — |
| Q4 2022 | May 19, 2022 | −$0.59 | −$0.61 | −2.24% | $0.00 | — |
| Q3 2022 | Feb 3, 2022 | −$0.55 | −$0.57 | −3.39% | $0.00 | — |
| Q2 2022 | Nov 4, 2021 | −$0.51 | −$0.56 | −9.10% | $0.00 | — |
| Q1 2022 | Aug 6, 2021 | −$0.44 | −$0.53 | −20.15% | $0.00 | — |
| Q4 2021 | May 20, 2021 | −$0.41 | −$0.41 | −0.44% | $0.00 | — |
| Q3 2021 | Feb 4, 2021 | −$0.41 | −$0.44 | −8.19% | $0.00 | — |
| Q2 2021 | Nov 5, 2020 | −$0.44 | −$0.46 | −4.81% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did Replimune Group (REPL) last report earnings?
Replimune Group last reported on Aug 7, 2025, covering fiscal Q1 2026.
Did REPL beat earnings estimates?
No. Replimune Group reported EPS of −$0.95 for Q1 2026 against a −$0.79 estimate — a 19.57% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.